195 patents
Page 7 of 10
Utility
Genetic Marker And/or Biomarkers for Traumatic Brain Injury, and Ultrasensitive Assays for Biomarkers of Traumatic Brain Injury
18 Feb 21
The present invention relates to assays, methods, and kits to assess traumatic brain injury (TBI) in a subject.
Jeff DEBAD, Joshua GATSON, Mark BURNS, Arianna BIESSO
Filed: 8 Mar 19
Utility
Diverting Jejunostomy Tube
11 Feb 21
An enteral feeding device permitting diversion of gastrointestinal fluid from an afferent limb to an efferent limb of gastrointestinal tract in a subject is provided.
Emil COHEN
Filed: 29 Mar 19
Utility
Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections
11 Feb 21
In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infection by administering artemisinin-related compounds.
Richard Schlegel, Dan-Paul Hartmann, Astrid Baege
Filed: 16 Oct 20
Utility
Predicting drug-target interactions and uses for drug repositioning and repurposing
9 Feb 21
Described herein are methods of predicting drug-target interactions and methods of using the information for drug repurposing.
Sivanesan Dakshanamurthy, Stephen W. Byers
Filed: 3 Jun 16
Utility
Determining stereoisomeric excess, concentration and absolute configuration
26 Jan 21
The present invention is directed to analytical methods for determining the concentration, and/or stereoisomeric excess, and/or absolute configuration of chiral analytes in a sample.
Christian Wolf, Keith Bentley, Burcin Irfanoglu, Peng Zhang
Filed: 8 Jun 18
Utility
Protein biomarkers for memory loss
26 Jan 21
The present invention relates to methods of determining if a subject has an increased risk of suffering from memory impairment.
Howard J. Federoff, Massimo S. Fiandaca, Amrita K. Cheema, Mark E. Mapstone, Xiaogang Zhong
Filed: 17 Oct 16
Utility
Metabolic biomarkers for memory loss
26 Jan 21
The present invention relates to methods of determining if a subject has an increased risk of suffering from memory impairment.
Howard J. Federoff, Massimo S. Fiandaca, Amrita K. Cheema, Mark E. Mapstone
Filed: 18 May 16
Utility
Detecting COVID-19 using surrogates
26 Jan 21
A triage system that determines whether a user is likely to have contracted a disease based on sensor data received from a user device (e.g., a smartphone or activity tracker).
Howard Federoff, Ophir Frieder
Filed: 19 May 20
Utility
Translator with Improved Database Information Transmission
21 Jan 21
Technology for providing a translated content item containing text is disclosed.
Ophir Frieder, Joe Garman
Filed: 6 Aug 20
Utility
Compositions and methods for single G-level HLA typing
12 Jan 21
Provided are methods, kits, and systems useful in the performance of analysis and reporting of highly polymorphic loci, including, in particular, the performance of analysis and reporting of HLA typing.
Jennifer Ng, Carolyn K. Hurley, Bin Tu, Carly Masaberg
Filed: 24 Sep 13
Utility
Stripline detector for in situ battery NMR
12 Jan 21
Provided are batteries and fuel cells incorporating a stripline detector for use in nuclear magnetic resonance (NMR).
YuYe J. Tong, Eric G. Sorte
Filed: 21 Aug 17
Utility
Metabolic biomarkers for memory loss
12 Jan 21
The present invention relates to methods of determining if a subject has an increased risk of suffering from memory impairment.
Massimo S. Fiandaca, Mark E. Mapstone, Howard J. Federoff, Xiaogang Zhong, Amrita K. Cheema
Filed: 27 May 15
Utility
Treating Neural Disease with Tyrosine Kinase Inhibitors
30 Dec 20
Provided herein are methods of treating or preventing a neurodegenerative disease, a myodegenerative disease or a prion disease in a subject comprising administering a tyrosine kinase inhibitor.
Charbel Moussa
Filed: 22 Jun 20
Utility
Application Programming Interface and Hypergraph Transfer Protocol Supporting a Global Hypergraph Approach to Reducing Complexity For Accelerated Multi-Disciplinary Scientific Discovery
9 Dec 20
A system and method for connecting one or more client applications with one or more knowledge representation servers and communicating there between includes an application programming interface (API) and a hypergraph transfer protocol (HGTP), for facilitating communication between the one or more client applications and one or more knowledge representation servers responsive to a client application request.
J. Cory Smart
Filed: 29 Jun 20
Utility
USE OF Kv11.1 CHANNEL INHIBITORS FOR TREATMENT OF PULMONARY HYPERTENSION
9 Dec 20
Provided are methods of treating pulmonary artery hypertension with a Kv11.1 (ERG or hERG1) channel inhibitor.
Tinatin I. Brelidze, Yuichiro J. Suzuki, Nataliia Shults, Vladyslava Rybka
Filed: 20 May 20
Utility
Treating Cancer with a CCK Receptor Inhibitor and an Immune Checkpoint Inhibitor
9 Dec 20
Provided herein are methods for treating a cholecystokinin (CCK) receptor-expressing cancerous tumor in a subject.
Jill P. Smith, Louis Weiner, Sandra Jablonski, Sandeep Nadella, Shangzi Wang
Filed: 14 Mar 18
Utility
Methods of Treating Residual Lesions of Vascular Anomalies
9 Dec 20
Compositions comprising bile acids or their salts and methods of use thereof for the treatment of residual lesions of vascular anomalies.
Cynthia Marie Carver DEKLOTZ, Michael Andrew CARDIS
Filed: 16 Dec 18
Utility
Assessing Diseases by Analyzing Gait Measurements
2 Dec 20
A gait analysis system, which includes a neural network with a recurrent neural network layer and a fully connected layer, that receives sensor data indicative of an individual's gait and outputs an assessment regarding the individual's health.
Gholam MOTAMEDI, Ophir Frieder, Cristopher Flagg
Filed: 31 May 20
Utility
Apoe Modifications and Uses Thereof
25 Nov 20
Provided herein are methods for detecting a cerebrospinal fluid-specific (CSF-specific) glycoform of Apolipoprotein E (APOE) in a subject.
George William Rebeck, Sarah Flowers
Filed: 14 Aug 18
Utility
Methods of Assessing Future Memory Loss by Measuring Polyunsaturated Fatty Acids
18 Nov 20
The present invention relates to methods of determining if a subject has an increased risk of suffering from memory impairment.
Massimo S. Fiandaca, Howard J. Federoff
Filed: 31 May 20